0102030405
Silodosine Intermediates CAS No 160969-03-9 Pharmaceutical Intermediates
02
overview
Silodosine Intermediate is a specialty pharmaceutical compound that plays an important role in oncology.
As a selective inhibitor of MEK1 and MEK2 kinases, Silodosine Intermediate disrupts the MAPK/ERK signaling pathway, which is often overactive in various cancers.
This compound is particularly effective in treating tumors with BRAF mutations, making it a valuable addition to targeted cancer therapies.
Its unique mechanism of action can inhibit cancer cell proliferation and survival, providing a promising treatment option for patients with specific malignancies.
As a selective inhibitor of MEK1 and MEK2 kinases, Silodosine Intermediate disrupts the MAPK/ERK signaling pathway, which is often overactive in various cancers.
This compound is particularly effective in treating tumors with BRAF mutations, making it a valuable addition to targeted cancer therapies.
Its unique mechanism of action can inhibit cancer cell proliferation and survival, providing a promising treatment option for patients with specific malignancies.
02
Physical and chemical properties
- Solubility: The compound is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, thus providing flexibility in its application during the manufacturing process.
- Melting Point: Silodosine Intermediate has a melting point of approximately 150-155°C, indicating that it is stable under standard laboratory conditions.
- Storage Conditions: Should be stored in a cool, dry place away from light and moisture to maintain its integrity and effectiveness.
- Melting Point: Silodosine Intermediate has a melting point of approximately 150-155°C, indicating that it is stable under standard laboratory conditions.
- Storage Conditions: Should be stored in a cool, dry place away from light and moisture to maintain its integrity and effectiveness.
1. Pharmaceutical Relevance: Silodosine Intermediate is essential for the development of targeted therapies for cancer treatment. Its ability to inhibit MEK1 and MEK2 makes it a key component in the management of MAPK pathway-driven tumors.
2. High Efficiency: As a MEK inhibitor, Silodosine Intermediate has shown significant anti-tumor activity in clinical studies, especially for patients with BRAF mutant melanoma and other solid tumors. This efficacy is crucial to improving the prognosis of oncology patients.
3. Cost-Efficient Sourcing: By sourcing Silodosine Intermediate directly from our integrated production facilities, you can enjoy competitive pricing without compromising on quality. This cost-effectiveness is critical to maintaining profitability in pharmaceutical manufacturing.
4. Quality Assurance: Our commitment to quality means that every batch of Silodosine Intermediate is rigorously tested to ensure it meets the highest industry standards. This reliability is critical for pharmaceutical companies that require consistent and high-quality raw materials.
5. Expert Support: Our team of experts can provide you with technical support and guidance on best practices for using Silodosine Intermediate in your applications. We understand the complexities of pharmaceutical manufacturing and are here to help you.
2. High Efficiency: As a MEK inhibitor, Silodosine Intermediate has shown significant anti-tumor activity in clinical studies, especially for patients with BRAF mutant melanoma and other solid tumors. This efficacy is crucial to improving the prognosis of oncology patients.
3. Cost-Efficient Sourcing: By sourcing Silodosine Intermediate directly from our integrated production facilities, you can enjoy competitive pricing without compromising on quality. This cost-effectiveness is critical to maintaining profitability in pharmaceutical manufacturing.
4. Quality Assurance: Our commitment to quality means that every batch of Silodosine Intermediate is rigorously tested to ensure it meets the highest industry standards. This reliability is critical for pharmaceutical companies that require consistent and high-quality raw materials.
5. Expert Support: Our team of experts can provide you with technical support and guidance on best practices for using Silodosine Intermediate in your applications. We understand the complexities of pharmaceutical manufacturing and are here to help you.
In conclusion, Silodosine Intermediate is an important compound for the pharmaceutical industry with high purity, high efficacy and high cost-effectiveness.
As a factory integrating production and trading, we are committed to providing customers with the highest quality products and excellent services.
By choosing our Silodosine Intermediate, you can ensure that your drug formulation is built on quality and reliability.
Contact us today to learn more about our products and how we can support your business needs.
As a factory integrating production and trading, we are committed to providing customers with the highest quality products and excellent services.
By choosing our Silodosine Intermediate, you can ensure that your drug formulation is built on quality and reliability.
Contact us today to learn more about our products and how we can support your business needs.